文献速递淋巴瘤

微小RNA-15与微小RNA-16表达替代对慢性淋巴细胞白血病的影响:治疗意义

Effects of miRNA-15 and miRNA-16 expression replacement in chronic lymphocytic leukemia: implication for therapy.
PubMed 文献 · Leukemia · 2017-01-05

慢性淋巴细胞白血病(CLL)克隆以13q14.3缺失为特征,该区域涉及miR-15a和miR-16-1。转染这两种miRNA模拟物可降低CLL细胞体外活力并损害其在NSG小鼠中的植入与生长能力,二者联合无协同效应;对已植入CLL克隆的NSG小鼠给予miRNA模拟物可致显著肿瘤消退,而特异性抑制剂则增强细胞活力及植入生长能力。

要点

  • 转染miR-15a和miR-16-1模拟物降低CLL细胞体外活力并损害NSG小鼠植入生长能力。
  • 两种miRNA模拟物联合未见协同效应。
  • 对已植入CLL克隆的NSG小鼠给予miRNA模拟物可致显著肿瘤消退。

核心结论

  • miR-15a和miR-16-1对CLL克隆扩增的强控制也作用于完整白血病层面,并为基于miRNA的治疗策略提供依据。

研究设计与样本

  • 研究将miR-15a和miR-16-1模拟物或特异性抑制剂转染CLL细胞,并在NOD/Shi-scid,γcnull(NSG)小鼠中评估植入与生长。

主要发现

  • 转染miR-15a和miR-16-1模拟物的CLL细胞体外活力下降,在NSG小鼠中植入和生长能力受损。
  • 两种miRNA模拟物联合时未观察到协同效应。
  • 上述现象不限于携带del(13)(q14)病变的CLL,除某些携带TP53改变的CLL克隆外,存在其他染色体异常的细胞也可见类似效应。
  • 对已植入CLL克隆的NSG小鼠给予miRNA模拟物导致显著肿瘤消退。
  • 转染miR-15a和miR-16-1特异性抑制剂的CLL细胞体外活力增加,植入细胞在NSG小鼠中生长能力增强并形成更大的脾结节。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chronic lymphocytic leukemia (CLL) clones are characterized by loss of a critical region in 13q14.3, (del(13)(q14)) involving the microRNA (miRNA) cluster miR-15a and miR-16-1. We have investigated the effects of replacement of miR-15a and miR-16-1. CLL cells transfected with these miRNA mimics exhibited a decrease in cell viability in vitro and impaired capacity for engraftment and growth in NOD/Shi-scid,γcnull (NSG) mice. No synergistic effects were observed when the two miRNA mimics were combined. The phenomena were not restricted to CLL with the del(13)(q14) lesion. Similar effects induced by miRNA mimics were seen in cells with additional chromosomal abnormalities with the exception of certain CLL clones harboring TP53 alterations. Administration of miRNA mimics to NSG mice previously engrafted with CLL clones resulted in substantial tumor regression. CLL cell transfection with miR-15a and miR-16-1-specific inhibitors resulted in increased cell viability in vitro and in an enhanced capacity of the engrafted cells to grow in NSG mice generating larger splenic nodules. These data demonstrate that the strong control by miR-15a and miR-16-1 on CLL clonal expansion is exerted also at the level of full-blown leukemia and provide indications for a miRNA-based therapeutic strategy.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Cutrona G, Matis S, Colombo M, et al. Effects of miRNA-15 and miRNA-16 expression replacement in chronic lymphocytic leukemia: implication for therapy. Leukemia. 2017. PMID: 28053325. doi:10.1038/leu.2016.394

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。